April 15, 2019 – As the debate over consumer data privacy continues and digital marketing has become increasing complex, a new “Privacy for America” coalition has formed to work with Congress to support “enactment of groundbreaking comprehensive federal consumer data privacy and security legislation,” according to an April 8 press release. The group is designed […]
Read more March 1, 2018 – After filing an amendment to the tax bill last year to eliminate the tax deduction for drug marketing expenses — which did not move forward — Sen. Claire McCaskill (D-Mo.) today announced a bill that would amend the tax code to “deny the deduction for advertising and promotional expenses for prescription […]
Read more
June 13, 2016 – Before and after the 2016 elections, Washington health policy will remain fixed on improving the path to drug innovation, achieving legislative reform to secure that path, and responding to concerns about drug pricing, according to Prevision Policy’s Kate Rawson, who spoke at the recent Coalition for Healthcare Communication Rising Leaders Conference […]
Read moreFeb. 18, 2016 – A bill introduced in the House last week by Rep. Rosa DeLauro (D-Conn.) — the Responsibility in Drug Advertising Act of 2016 (H.R. 4565) – would prohibit direct-to-consumer (DTC) advertising for the first three years following a drug’s approval and allow the Department of Health and Human Services (HHS) to waive […]
Read moreJuly 29, 2014 – Industry groups and physician organizations have banded together to petition the Centers for Medicare & Medicaid Services (CMS) to address “certain pressing issues” related to implementation of the Sunshine Act. The first request in the July 28 letter, signed by 26 groups, is that CMS provide physicians and industry stakeholders with […]
Read moreMay 29, 2014 – The Federal Trade Commission (FTC) released a report May 27 in which it asks Congress to consider legislation that would require data brokers to provide consumers with access to their data and give them the ability to opt out of having that information shared. These legislative recommendations “would begin to build […]
Read moreFeb. 27, 2014 – As expected, tax reform legislation introduced yesterday by Senate Ways and Means Committee Chairman Dave Camp (R-Mich.) includes a provision limiting the advertising cost deductions to 50 percent over the first year with an amortization of the remaining deductions over 10 years, with a loophole for the first million dollars of […]
Read moreJan. 15, 2013 – If 2012 – with its high number of new drug approvals, senior staff stability within the FDA and the Department of Health & Human Services (HHS) and a definitive decision about the Affordable Care Act (ACA) – is an indicator, then the 2013 Washington outlook for pharmaceutical companies is promising. However, […]
Read moreJune 15, 2012 – The Coalition for Healthcare Communication joined other major marketing trade groups asking the Senate Committee on Appropriations to “delete” a directive from the Financial Services and General Government Subcommittee which would mandate that the Federal Communications Commission (FCC) and the Federal Trade Commission (FTC) issue consumer best practices for protecting personal […]
Read moreApril 23, 2012 — The House and Senate both issued draft legislation last week to reauthorize the Prescription Drug User Fee Act and with mark-ups imminent, Congress appears to be on track for passing the PDUFA V legislation by mid-year. “The news from Capitol Hill on PDUFA V reauthorization of the FDA is great,” said […]
Read more